Trials / Unknown
UnknownNCT01217320
Creatine Supplementation in Pediatric Rheumatology
Efficacy and Safety of Creatine Supplementation in Patients With Juvenile Systemic Lupus Erythematosus and Juvenile Dermatomyositis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Creatine supplementation may improve strength, muscle mass, bone mass and muscle function in healthy and elderly people. The investigators speculate that creatine supplementation could have therapeutic effects in pediatric rheumatic (i.e., juvenile systemic lupus erythematosus and juvenile dermatomyositis) patients who usually present muscle weakness, muscle wasting and bone mass loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | creatine | 5g/d throughout 12 weeks |
| DIETARY_SUPPLEMENT | placebo (dextrose) | 5g/d throughout 12 weeks |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2010-10-08
- Last updated
- 2012-01-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01217320. Inclusion in this directory is not an endorsement.